Empowered! artwork

Empowered!

59 episodes - English - Latest episode: 4 days ago - ★★★★★ - 1 rating

Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome.Our programs enhance patient health literacy to enable shared decision-making and provide informational and educational resources to empower patients and care partners at every step of their cancer journey.

Medicine Health & Fitness patient empowerment cancer patients
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

Evolving Myelofibrosis Treatment Options: What You Should Know

April 24, 2024 15:00 - 30 minutes - 21.1 MB

Myelofibrosis treatment and care is evolving quickly so it’s essential to understand your options and work with your healthcare team when making treatment decisions. In this webinar, Dr. Gaby Hobbs will discusses the latest updates in research and clinical trials, the role of new and emerging myelofibrosis therapies, and shares advice for accessing quality care. Dr. Gabriela Hobbs is a hematology-oncology physician specializing in the care of patients with myeloproliferative neoplasms (MPN)...

Kidney Cancer Patient Expert Q&A: Dr. Moshe Ornstein

April 17, 2024 13:00 - 30 minutes - 21 MB

START HERE bridges the expert and patient voice, enabling patients facing a kidney cancer diagnosis to feel comfortable asking precise questions of their healthcare team. In this program, Dr. Moshe Ornstein offers invaluable insights into renal cell carcinoma (RCC), equipping newly diagnosed patients with essential information on treatment priorities, as well as strategies for managing progression and recurrence. Download Resource Guide

Myeloma Patient Expert Q&A: Dr. Sikander Ailawadhi

April 10, 2024 14:00 - 39 minutes - 26.9 MB

 In this START HERE myeloma program, Dr. Sikander Ailawadhi from Mayo Clinic spotlights priorities in the rapidly expanding myeloma treatment landscape. Watch as Dr. Ailawadhi addresses pressing questions submitted by patients and families, providing invaluable guidance and reassurance in navigating the complexities of myeloma care. Download Guide  |  Descargar Guía See More from START HERE Myeloma

Head & Neck Cancer: What Do You Need to Know About Evolving Treatment and Research?

April 03, 2024 13:00 - 37 minutes - 25.8 MB

Head and neck cancer research is evolving rapidly, leading to expanded treatment options for patients. Expert and researcher Dr. Ezra Cohen discusses key factors that impact head and neck cancer treatment decisions, reviews emerging research, and provides tips for collaborating with your healthcare team. Dr. Ezra Cohen is a medical oncologist, head and neck cancer researcher and Chief Medical Officer of Oncology at Tempus Labs. Download Resource Guide

Thrive | Considering CAR T-Cell Therapy for Myeloma? What You Should Know

March 20, 2024 15:00 - 35 minutes - 24.5 MB

Dr. Beth Faiman, a myeloma expert and researcher, discusses factors that should be considered when deciding to undergo CAR T-cell therapy, advice for preparing for and after the process, and why a good support team is essential. Dr. Faiman also shares research updates in CAR T-cell therapy, and alternatives options to this myeloma treatment. Dr. Beth Faiman is an Adult Nurse Practitioner in the department of Hematologic Oncology and Blood Disorders at the Cleveland Clinic. Learn more about ...

HCP Roundtable: Critical Clinical Trial Conversations in the Expanding Myeloma Landscape

March 13, 2024 14:00 - 32 minutes - 22.4 MB

Treatment options for multiple myeloma have increased substantially, mainly attributed to advancements in clinical trials. More than ever, HCPs having conversations about trials is critical. Given that underrepresented communities bear a disproportionate burden of multiple myeloma, it becomes imperative to shift this paradigm. What are the optimal approaches to initiate these conversations early in the patient journey? How should HCPs effectively communicate information about clinical trial...

HCP Roundtable: Best Practices for Talking About Clinical Trials With Myeloma Patients

March 06, 2024 16:00 - 28 minutes - 19.3 MB

Clinical trials represent tomorrow’s medicine today, yet not every patient confronting a myeloma diagnosis is informed about all available care options. Surprisingly, some patients and their care partners are never introduced to the possibility of participating in clinical trials. How can we alter the course? What strategies can healthcare professionals (HCPs) employ to effectively communicate information about clinical trials and guide patients through next steps? Experts Dr. Beth Faiman a...

Follicular Lymphoma Patient Expert Q&A: Dr. Kami Maddocks

January 24, 2024 15:00 - 35 minutes - 24.2 MB

Follicular lymphoma expert, Dr. Kami Maddocks discusses the latest in follicular lymphoma, meaningful highlights from the American Society of Hematology 2023 meeting and answers questions submitted by patients and care partners. Dr. Maddocks is a hematologist/oncologist specializing in treating lymphatic diseases from The Ohio State University.  See More from START HERE Follicular Lymphoma Download Guide | Descargar Guía

Gastric Cancer: How to Access the Best Care and Treatment for YOU

December 13, 2023 14:00 - 30 minutes - 21.2 MB

Advances in gastric cancer research have led to more personalized therapy for patients. Dr. Yelena Janjigian discusses how biomarker testing can help guide a patient’s prognosis and treatment path, reviews currently available gastric cancer therapies, and shares tips for self-advocacy. Dr. Yelena Janjigian is Chief of Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center.  See More From INSIST! Gastric Cancer Download Resource Guide

What Non-Small Cell Lung Cancer Treatment is Right for You?

December 06, 2023 15:00 - 26 minutes - 18.5 MB

What’s the best approach for YOUR lung cancer? Dr. Isabel Preeshagul discusses the importance of engaging in your lung cancer care decisions, shares advice for working with your team to determine a treatment approach, and reviews factors that affect therapy options. Dr. Preeshagul also provides an update on the latest research and clinical trials. Dr. Isabel Preeshagul is a thoracic medical oncologist at Memorial Sloan Kettering Cancer Center.  Download Program Resource Guide See More Fro...

Thrive | Advice for Managing Potential CAR T-Cell Therapy Side Effects

November 29, 2023 15:00 - 28 minutes - 19.8 MB

Dr. Adriana Rossi, a myeloma expert and researcher, discusses how CAR T-cell therapy has revolutionized care, the process for undergoing this therapy, common side effects of this treatment, and advice for patients considering this option. Dr. Rossi also shares updates in CAR T-cell therapy research and explains what she’s excited about in myeloma care. Dr. Adriana Rossi is Co-director of the CAR T and stem cell transplant program at the Center for Excellence for Multiple Myeloma at Mount Si...

CLL Patient Expert Q&A: Dr. Danielle Brander

November 08, 2023 16:00 - 35 minutes - 24.6 MB

START HERE bridges the expert and patient voice, enabling chronic lymphocytic leukemia (CLL) patients to feel comfortable asking questions of their healthcare team with precision. In this program, CLL expert Dr. Danielle Brander speaks to managing CLL side effects, emerging novel CLL therapies and treatment options for CLL progression. Dr. Danielle Brander is an Assistant Professor in the Division of Hematologic Malignancies & Cellular Therapy at Duke University Medical Center. Learn more a...

CAR T-Cell Therapy Care Partners | Understanding Your Role in Patient Care and Recovery

November 01, 2023 14:00 - 31 minutes - 21.6 MB

Understanding CAR T-cell therapy and recovery is vital for care partners who are caring for a loved one undergoing this treatment approach. Dr. Shambavi Richard explains the CAR T-cell therapy process, potential complications, ongoing research in the field, and discusses how care partners can provide support at each stage of the process. Dr. Shambavi Richard is the Co-Lead Physician for the Multiple Myeloma CAR-T Program at Mount Sinai Tisch Cancer Center. Learn more about Dr. Shambavi Rich...

Follicular Lymphoma Patient Expert Q&A: Start Here

October 25, 2023 13:00 - 31 minutes - 21.8 MB

The START HERE program bridges lymphoma expert and patient voice, whether you are newly diagnosed, in active treatment or in watch and wait. In this webinar, Dr. Sameh Gaballa provides an overview of the latest in follicular lymphoma, emerging therapies, clinical trials and options for follicular lymphoma progression and recurrence. Dr. Sameh Gaballa is a hematologist/oncologist specializing in treating lymphoid malignancies from Moffitt Cancer Center. Learn more about Dr. Gaballa. See Mor...

Managing Life With AML | What You Should Know About Care and Treatment

October 18, 2023 16:00 - 31 minutes - 21.7 MB

What do you need to know when it comes to managing life with acute myeloid leukemia (AML)? In this webinar, Dr. Alice Mims, an AML specialist and researcher, discusses how treatment decisions are made and how test results may impact therapy. Dr. Mims will shares the latest advances in research and key advice for living well with AML. Dr. Alice Mims is a hematologist specializing in acute and chronic myeloid conditions. Dr. Mims serves as the Acute Leukemia Clinical Research Director at The ...

Why Test Results Matter | Accessing Personalized Non-Small Cell Lung Cancer Treatment

October 04, 2023 16:00 - 34 minutes - 23.7 MB

Can test results affect non-small cell lung cancer treatment options? Dr. Erin Schenk reviews essential lung cancer testing, discusses how the results may influence treatment approaches, and explains why it’s important for patients to take an active role in their care and treatment choices. Dr. Erin Schenk is a medical oncologist, lung cancer researcher, and assistant professor in the division of medical oncology at the University of Colorado Anschutz Medical Center. Download Program Resou...

Thriving With an MPN | Managing Symptoms and Treatment Side Effects

September 27, 2023 14:00 - 37 minutes - 25.9 MB

In this podcast, MPN specialist Dr. Naveen Pemmaraju, discusses strategies for managing symptoms and treatment side effects for people living with essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Dr. Pemmaraju also shares advice for communicating with your healthcare team and provides an update on the latest MPN treatment and research. Dr. Naveen Pemmaraju is Director of the Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Program in the Department of Leuk...

PODCAST: Thriving With an MPN | Managing Symptoms and Treatment Side Effects

September 27, 2023 14:00 - 37 minutes - 25.9 MB

In this podcast, MPN specialist Dr. Naveen Pemmaraju, discusses strategies for managing symptoms and treatment side effects for people living with essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Dr. Pemmaraju also shares advice for communicating with your healthcare team and provides an update on the latest MPN treatment and research. Dr. Naveen Pemmaraju is Director of the Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Program in the Department of Leuk...

Thriving With AML | Tips and Support for Navigating Treatment

September 20, 2023 15:00 - 32 minutes - 22.2 MB

How can you navigate care and thrive with acute myeloid leukemia (AML)? In this webinar, Dr. Jacqueline Garcia, an AML specialist and researcher, discusses the treatment and management of AML. Dr. Garcia will review factors that impact therapy choices and shares advice and resources for people living with AML. Dr. Jacqueline Garcia is an oncologist and AML researcher at the Dana-Farber Cancer Institute. Learn more about Dr. Garcia. Download Resource Guide See More from Thrive AML

PODCAST: Advanced Non-Melanoma Skin Cancer What Do You Need to Know About Evolving Treatment and Research

September 13, 2023 14:00 - 29 minutes - 20.2 MB

Treatment options for advanced non-melanoma skin cancers—such as squamous and basal cell carcinoma—are evolving quickly. Dr. Diwakar Davar shares an update on emerging research, discusses current treatment options, and provides tips for partnering with your team on care decisions. Dr. Diwakar Davar is the Clinical Director of the Melanoma and Skin Cancer Program at UPMC Hillman Cancer Center. Learn more about Dr. Davar. See More from Evolve Non-Melanoma Skin Cancer

Advanced Non-Melanoma Skin Cancer What Do You Need to Know About Evolving Treatment and Research

September 13, 2023 14:00 - 29 minutes - 20.2 MB

Treatment options for advanced non-melanoma skin cancers—such as squamous and basal cell carcinoma—are evolving quickly. Dr. Diwakar Davar shares an update on emerging research, discusses current treatment options, and provides tips for partnering with your team on care decisions. Dr. Diwakar Davar is the Clinical Director of the Melanoma and Skin Cancer Program at UPMC Hillman Cancer Center. Learn more about Dr. Davar. See More from Evolve Non-Melanoma Skin Cancer

Advanced Prostate Cancer: How to Access the Best Care and Treatment for YOU

September 06, 2023 15:00 - 32 minutes - 22.2 MB

Progress in advanced prostate cancer has led to more personalized treatment options and individualized care for people with this diagnosis. Dr. Xin Gao discusses how the results of essential testing can help guide a patient’s prognosis and treatment path, reviews available therapies, and shares advice for self-advocacy. Dr. Xin Gao is a Medical Oncologist at Massachusetts General Hospital. Learn more about this expert. Download Resource Guide See More From INSIST! Prostate Cancer

HCP Roundtable: Shared Decision-Making in Myeloproliferative Neoplasm (MPN) Care

August 30, 2023 13:00 - 37 minutes - 26 MB

What does shared decision-making look like in myeloproliferative neoplasm care? How should fellow MPN specialists explain disease progression to patients and care partners? In this HCP-to-HCP roundtable discussion, experts Dr. Gabriela Hobbs and Natasha Johsnon share best practices for helping your MPN patients play an active role in managing their health. Dr. Gabriela Hobbs is a hematology-oncology physician specializing in the care of patients with myeloproliferative neoplasms (MPN), chro...

What Do You Need to Know About Emerging Endometrial Cancer Research?

August 23, 2023 13:00 - 33 minutes - 22.9 MB

Endometrial cancer treatment and research is evolving quickly. Dr. Emily Ko provides an update on new and emerging approaches, explains how these therapies work to treat endometrial cancer, and shares tips for partnering with your team on key decisions. Dr. Emily Ko is a gynecologic oncologist and Associate Professor of Obstetrics and Gynecology at the University of Pennsylvania. Learn more about Dr. Ko.  

MPN Specialized Care and Technology: Digital Health and Symptom Management

August 09, 2023 17:00 - 49 minutes - 33.9 MB

Nearly 80% of patients living with a myeloproliferative neoplasm (MPN) are affected by fatigue. Can digital health alleviate symptom burden in MPN care? What exactly is mobile app intervention, and how can it help me? Dr. Krisstina Gowin and Dr. AnaMaria Lopez discuss technological interventions in MPN symptom management, telemedicine limitations and the importance of connecting with an MPN specialist.   See More from MPN TelemEDucation

Updates in Prostate Cancer Treatment and Research | What You Need to Know

August 02, 2023 13:00 - 31 minutes - 21.5 MB

With research evolving quickly, it’s more important than ever that people with prostate cancer take an active role in their care. Dr. Channing Paller shares an update on recent prostate care treatment advances, discusses essential testing--including genetic testing--and provides advice for self-advocacy. Channing Paller, MD is the Director of Prostate Cancer Clinical Research at Johns Hopkins Medicine. See More From INSIST! Prostate Cancer

Your Path to Empowerment: Multiple Myeloma | Clinical Trials

July 19, 2023 14:00 - 1 hour - 53.4 MB

Have you ever wanted to a hear a first-hand account from someone who has participated in a clinical trial? Hear from two patients as they describe their experience with enrollment and participation in a trial. Also, keep watching for our LIVE Q&A session with patient panelists and Myeloma expert, Dr. Manni Mohyuddin as they answer questions received from our audience. 

CLL Patient Expert Q&A: Start Here

June 26, 2023 15:00 - 47 minutes - 32.4 MB

The START HERE program bridges the CLL expert and patient voice, whether you are newly diagnosed, in active treatment or in watch and wait. In this webinar, Empowerment lead Lisa Hatfield and expert Dr. Ryan Jacobs  provide an overview of the latest in CLL, managing CLL side effects and options for CLL progression. Dr. Ryan Jacobs is a hematologist/oncologist specializing in Chronic Lymphocytic Leukemia from Levine Cancer Institute. Learn more about Dr. Jacobs. See More from Start Here CLL.

CAR T-Cell Therapy Care Partners | What Do You Need to Know About the Process?

June 26, 2023 15:00 - 31 minutes - 21.9 MB

What is the role of the care partner when a loved one is undergoing CAR T-cell therapy? Registered nurse and transplant coordinator Sarah Meissner is joined by Adrienne, a care partner, as they discuss the importance of care partners in the CAR T-cell therapy process. They review key questions to ask the healthcare team, explain patient side effects to monitor for, and share resources that can help support care partners throughout their loved one’s recovery period. Sarah Meissner, RN, BSN, ...

Accessing Personalized Myeloma Treatment | What Patients Should Know

June 26, 2023 15:00 - 31 minutes - 21.3 MB

Myeloma experts Dr. Francesca Cottini and Dr. Ashley Rosko provide an overview of the latest advances in essential testing for myeloma and explain how results could affect care and treatment decisions. Drs. Cottini and Rosko also review available myeloma therapies and their hopes for the future of patient care. Dr. Francesca Cottini is Assistant Professor in the Division of Hematology at the Ohio State University Comprehensive Cancer Center. Learn more about Dr. Cottini. Dr. Ashley Rosko i...

Thriving With Breast Cancer | Tools for Navigating Care and Treatment

May 22, 2023 16:00 - 35 minutes - 24.5 MB

How can patients live well with breast cancer? Dr. Bhuvaneswari Ramaswamy reviews current and emerging breast cancer treatments, discusses the importance of emotional support, and shares advice and resources for engaging in care decisions. Dr. Bhuvaneswari Ramaswamy is the Section Chief of Breast Medical Oncology and the Director of the Medical Oncology Fellowship Program in Breast Cancer at The Ohio State College of Medicine. Learn more about Dr. Ramaswamy. See More from the Empowered! Po...

Head & Neck Cancer Treatment Decisions: What’s Right for You?

May 22, 2023 16:00 - 29 minutes - 20.3 MB

When considering treatment options for head and neck cancer, what helps determine the best approach for YOU? Dr. Ari Rosenberg discusses key factors that impact head and neck cancer treatment decisions, emerging research, and tips for partnering with your healthcare team. Dr. Ari Rosenberg is a medical oncologist and assistant professor of medicine at The University of Chicago Medicine. Learn more about Dr. Rosenberg. See More from the Empowered! Podcast

Managing Life With an MPN | What You Need to Know

May 22, 2023 16:00 - 28 minutes - 19.4 MB

MPN expert Dr. Raajit Rampal shares advice for making treatment decisions for patients with essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Dr. Rampal also reviews tips and tools for managing symptoms and side effects and provides an update on new and emerging MPN therapies. Dr. Raajit Rampal is a hematologist-oncologist specializing in the treatment of myeloproliferative neoplasms (MPNs) and leukemia at Memorial Sloan Kettering Cancer Center in New York City...

Expert Advice for Navigating AML Treatment and Care Decision

May 22, 2023 15:00 - 31 minutes - 21.7 MB

AML expert Dr. Ann-Kathrin Eisfeld reviews the importance of essential testing and explains how the results may impact the care and treatment of patients with AML. Dr. Eisfeld also shares updates on new and developing AML research. Dr. Ann-Kathrin Eisfeld is Director of the Clara D. Bloomfield Center for Leukemia Outcomes Research at The Ohio State University and a member of the Leukemia Research Program at the OSUCCC – James. Learn more about Dr. Eisfeld. See More from the Empowered! Podc...

HCP Roundtable: Improving Clinician-Patient Conversations in Lung Cancer Biomarker Testing

May 22, 2023 15:00 - 37 minutes - 25.9 MB

Comprehensive biomarker testing can play a very important role in the personalized treatment for patients with non-small cell lung cancer (NSCLC). How do we improve clinician-patient conversations in biomarker testing? And how do we remove barriers that can impede an HCP’s ability to treat patients with personalized care? Dr. Heather Wakelee, Professor of Medicine and Chief of the Division of Oncology at Stanford University School of Medicine and Dr. Leigh Boehmer, medical director at Assoc...

PODCAST: Clinical Trials as a Prostate Cancer Treatment Option | What You Should Know

May 17, 2023 15:00 - 28 minutes - 19.9 MB

Should you consider participating in a prostate cancer clinical trial? Dr. Sumit Subudhi explains the clinical trial process, addresses common trial patient concerns, and provides key advice for trial participation. Dr. Subudhi also shares an update on promising prostate cancer research. Dr. Sumit Subudhi is an Associate Professor in the Department of Genitourinary Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center.

Clinical Trials as a Prostate Cancer Treatment Option | What You Should Know

May 17, 2023 15:00 - 28 minutes - 19.9 MB

Should you consider participating in a prostate cancer clinical trial? Dr. Sumit Subudhi explains the clinical trial process, addresses common trial patient concerns, and provides key advice for trial participation. Dr. Subudhi also shares an update on promising prostate cancer research. Dr. Sumit Subudhi is an Associate Professor in the Department of Genitourinary Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center.

What Should You Know About Emerging Myeloma Treatment Options?

May 10, 2023 17:00 - 32 minutes - 22.3 MB

With myeloma treatment and research advancing quickly, it’s important to stay up-to-date on the latest therapies. Myeloma expert Dr. Jeffrey Matous reviews new and emerging myeloma treatment approaches, how these therapies work, as well as the potential risks and benefits of each option. Dr. Matous also shares resources for learning about myeloma and how to access better care. About the Guest Dr. Jeffrey Matous is a myeloma specialist at the Colorado Blood Cancer Institute and the assistant...

MPN Specialized Care and Technology: The Ongoing Role of Telemedicine

May 03, 2023 15:00 - 53 minutes - 36.5 MB

Why should MPN patients keep telemedicine in their toolbox post-COVID? How can patients and caregivers feel more confident in voicing concerns and communicating with their healthcare teams regarding telemedicine options?  In this unique program, Drs. Jeanne Palmer and S. Joseph Sirintrapun discuss the impact of telemedicine on MPN care and technological tools accelerating the fight against cancer.

Myeloma Patient Expert Q&A: Start Here

April 05, 2023 15:00 - 54 minutes - 37.6 MB

In this myeloma patient expert Q&A, Mayo Clinic expert Dr. Sikander Ailawadhi provides highlights around the myeloma novel alphabet soup and actionable steps on how patients and care partners can start the treatment conversation. About the Guest:  Dr. Sikander Ailawadhi is a Professor of Medicine in the Division of Hematology/Oncology at Mayo Clinic Florida. See More from START HERE Myeloma.

HCP Roundtable: Overcoming Lung Cancer Biomarker Testing Challenges

March 31, 2023 13:00 - 32 minutes - 22.5 MB

The lung cancer field continues to experience tremendous growth in precision medicine. Oncologists have more tools to treat lung cancer, but access and language remains a big factor in biomarker testing. Drs. Jessica Bauman and Lyudmila Bazhenova discuss current issues in NSCLC biomarker testing, insights on how providers can explain biomarker testing to their patients and their families, and how academic centers and community physicians can work together to overcome challenges in biomarker ...

How Can You Engage in Your Myeloma Treatment Decisions?

March 31, 2023 13:00 - 30 minutes - 21.2 MB

Myeloma expert Dr. Benjamin Derman shares advice for partnering with your team when choosing a myeloma therapy, discusses important factors that should be considered, and provides key questions to ask your healthcare team to help you engage in your care. Dr. Derman also reviews research updates from the December 2022 American Society of Hematology (ASH) meeting. Abou the Guest: Dr. Benjamin Derman is a hematologist and oncologist specializing in multiple myeloma at the University of Chicago...

Thriving With Prostate Cancer | Tools for Navigating Care and Treatment

March 31, 2023 13:00 - 31 minutes - 21.8 MB

How can you thrive with prostate cancer? Dr. Tanya Dorff discusses prostate cancer treatment and developing research, side effect and symptom management, and shares advice and resources for coping with emotional issues. About the Guest: Dr. Tanya Dorff is Associate Professor in the Department of Medical Oncology & Therapeutics Research at City of Hope. See More from Thrive Prostate Cancer.

Replay: How Can You Access Personalized Lung Cancer Treatment?

September 22, 2021 18:00 - 30 minutes - 20.7 MB

How do diagnostic tests affect your lung cancer treatment plan. Dr. Tejas Patil discusses appropriate testing for lung cancer, latest targeted therapies and how emerging research is affecting patient outcomes. About the Guest: Dr. Tejas Patil is an academic thoracic oncologist at the University of Colorado Cancer Center focused on targeted therapies and novel biomarkers in lung cancer. Learn more about Dr. Patil, here. 

Staying Updated on AML Research News: Advice from an Expert

July 14, 2021 19:00 - 4 minutes - 3.44 MB

Dr. Jeffrey Lancet, an AML expert from Moffitt Cancer Center, shares tips for sifting through research news and encourages patients to communicate with their healthcare team about what they’ve learned.  About the Guest:  Dr. Jeffrey Lancet is Chair and Program Lead in the Department of Malignant Hematology at Moffitt Cancer Center in Tampa, FL. He is nationally and internationally recognized for his clinical research in the field of acute leukemias. Learn more about Dr. Lancet, here: https:...

What Are Essential Genetic Tests for Metastatic Breast Cancer Patients?

June 30, 2021 18:00 - 4 minutes - 3.22 MB

Following a metastatic breast cancer diagnosis, what tests are essential? In this podcast, Dr. Lisa Flaum reviews the role of key tests, and the impact of molecular (genetic) test results on treatment decisions. About the Guest: Dr. Lisa Flaum is a Medical Oncologist at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. 

Confused About AML Genetic Testing and Treatment? What You Need to Know.

June 16, 2021 17:00 - 4 minutes - 2.84 MB

What is AML genetic testing? Dr. Alice Mims explains genetic testing in AML, including the necessity of testing, the effect on treatment decisions, and why patients should be retested over the course of their disease. About the Guest: Dr. Alice Mims is a hematologist specializing in acute and chronic myeloid conditions. She serves as the Acute Leukemia Clinical Research Director at The Ohio State University Comprehensive Cancer Center – James. 

Treatment Approaches in AML: Key Testing for Personalized Care

June 02, 2021 19:00 - 31 minutes - 21.4 MB

When it comes to Acute Myeloid Leukemia (AML), genetic testing (or biomarker testing) is essential in helping to determine the best treatment approach for YOU. In this program, AML expert, Dr. Naval Daver reviews key decision-making factors, current AML treatments and emerging research for patients with AML.                                                                                  About the Guest: Dr. Naval Daver is an Associate Professor in the Department of Leukemia at The Univer...

Metastatic Breast Cancer: Accessing the Best Treatment For YOU

May 26, 2021 14:00 - 39 minutes - 27 MB

How could genetic testing results impact your metastatic breast cancer treatment options? In this podcast, Dr. Julie Gralow will discuss essential testing, the latest targeted therapies and emerging breast cancer research. About the Guest: Dr. Julie Gralow is the Jill Bennett Endowed Professor of Breast Medical Oncology at the University of Washington, Fred Hutchinson Cancer Research Center, and the Seattle Cancer Care Alliance. More about this expert: https://www.seattlecca.org/providers/j...

How is Acute Myeloid Leukemia (AML) Treated?

May 12, 2021 15:00 - 4 minutes - 3.04 MB

When diagnosed with Acute Myeloid Leukemia (AML), understanding available treatment options can be overwhelming. Dr. Alice Mims, an AML specialist, shares a brief overview of AML therapies and discusses factors to consider when deciding on an appropriate therapy with your healthcare team.  About the Guest:  Dr. Alice Mims is a hematologist specializing in acute and chronic myeloid conditions. She serves as the Acute Leukemia Clinical Research Director at The Ohio State University Comprehens...